18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
NCT03741231 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2019-05-06
Summary
Study the EFS and OS according to 18FDG PET in patients with melanoma or non small cell lung cancer treated by immunotherapy.
Conditions
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-01
- Primary Completion
- 2018-06-30
- Completion
- 2018-06-30
Countries
- France
Study Locations
More Related Trials
-
PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy
NCT04272658 ·Status: RECRUITING
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
Benefits Study of Respiratory-gated PET Acquisition in Lung Disease
NCT01812031 ·Status: COMPLETED ·Phase: NA
-
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NCT06082492 ·Status: RECRUITING ·Phase: NA
-
Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma
NCT04747561 ·Status: UNKNOWN ·Phase: NA
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA
-
Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma
NCT05681234 ·Status: COMPLETED ·Phase: NA
-
Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy
NCT03888950 ·Status: RECRUITING ·Phase: NA
-
Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT
NCT04464590 ·Status: COMPLETED
-
Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors
NCT03525080 ·Status: COMPLETED ·Phase: NA
-
[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers
NCT04320030 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer
NCT01619241 ·Status: UNKNOWN
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma
NCT03051542 ·Status: UNKNOWN ·Phase: NA
-
Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer
NCT02507518 ·Status: UNKNOWN ·Phase: PHASE2
-
Follow-up of Patients With Curative-intent Surgical Resection for NSCLC
NCT00199615 ·Status: COMPLETED ·Phase: NA
-
The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients
NCT04395651 ·Status: UNKNOWN
-
Pilot Study of 18F-FLT PET
NCT00585741 ·Status: TERMINATED ·Phase: NA
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma
NCT03051581 ·Status: UNKNOWN ·Phase: NA
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT
NCT01261585 ·Status: COMPLETED
-
Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
NCT00850278 ·Status: COMPLETED ·Phase: NA
-
PD-L1 PET Imaging in Melanoma Patients
NCT03520634 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN